Clínica Baviera, S.A. (BME:CBAV)

Clínica Baviera Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	265.72	227.07	198.45	173.25	122.63
Revenue Growth (YoY)	17.02%	14.42%	14.55%	41.28%	-1.37%
Cost of Revenue	133.18	115.1	96.55	84.05	64.23
Gross Profit	132.54	111.97	101.9	89.2	58.4
Selling, General & Admin	-	12.09	11.69	9.87	7.82
Other Operating Expenses	56.01	32.86	33.25	25.77	17.2
Operating Expenses	76.89	61.93	59.94	49.73	38.57
Operating Income	55.65	50.04	41.96	39.46	19.83
Interest Expense	-1.22	-0.57	-0.42	-0.46	-0.54
Interest & Investment Income	0.3	0.15	0.07	0	0.01
Earnings From Equity Investments	-0.02	-0.01	-0.06	-0.03	0.2
Currency Exchange Gain (Loss)	0.04	0.01	-0	-0	-
Other Non Operating Income (Expenses)	1.22	0.07	-0.4	-0.04	-0
EBT Excluding Unusual Items	55.96	49.68	41.15	38.93	19.51
Asset Writedown	0.03	-0.03	-0.47	-0.03	-
Other Unusual Items	-	-	-	-	0.68
Pretax Income	55.99	49.65	40.68	38.9	20.19
Income Tax Expense	14.86	12.92	10.53	10.97	6.05
Earnings From Continuing Operations	41.14	36.73	30.15	27.93	14.13
Minority Interest in Earnings	-0.93	-0.76	-0.63	-0.54	-0.19
Net Income	40.21	35.97	29.52	27.39	13.94
Net Income to Common	40.21	35.97	29.52	27.39	13.94
Net Income Growth	11.77%	21.86%	7.77%	96.46%	8.96%
Shares Outstanding (Basic)	16	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16	16
Shares Change (YoY)	-0.15%	-0.00%	-	0.01%	-0.01%
EPS (Basic)	2.47	2.21	1.81	1.68	0.86
EPS (Diluted)	2.47	2.21	1.81	1.68	0.86
EPS Growth	11.95%	21.86%	7.77%	96.43%	8.97%
Free Cash Flow	36.25	35.13	39.35	36.28	23.64
Free Cash Flow Per Share	2.23	2.15	2.41	2.23	1.45
Dividend Per Share	-	1.570	1.300	1.030	0.552
Dividend Growth	-	20.77%	26.21%	86.59%	-
Gross Margin	49.88%	49.31%	51.35%	51.49%	47.62%
Operating Margin	20.94%	22.04%	21.14%	22.78%	16.17%
Profit Margin	15.13%	15.84%	14.88%	15.81%	11.37%
Free Cash Flow Margin	13.64%	15.47%	19.83%	20.94%	19.28%
EBITDA	76.53	66.5	56.76	53.35	33.21
EBITDA Margin	28.80%	29.29%	28.60%	30.80%	27.08%
D&A For EBITDA	20.88	16.46	14.8	13.89	13.38
EBIT	55.65	50.04	41.96	39.46	19.83
EBIT Margin	20.94%	22.04%	21.14%	22.78%	16.17%
Effective Tax Rate	26.53%	26.02%	25.89%	28.19%	29.99%
Advertising Expenses	-	10.31	9.86	8.42	5.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.